UG

Ushaben Gigabhai Rathod

Active Director Director DIN 01981353
DIN 01981353 First appointment May 2008 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2008
Shareholding value •••• Premium profile

About Ushaben Gigabhai Rathod

Data last updated:

Ushaben Gigabhai Rathod is a Director at Jay Biotech Limited (since 2008). The company operates in Trading. Jay Biotech Limited reported revenue of ₹32.5 Lakh (FY 2025).

DIN 01981353
Primary Designation Director
Industry Trading
First Appointment 10 May 2008
Oldest Company Age 26 yrs
Largest company Jay Biotech Limited · ₹32.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jay Biotech Limited U24231GJ2000PLC038051
Director10 May 20082000₹32.5 Lakh (FY 2025)Active

Board colleagues of Ushaben Gigabhai Rathod

Directorship timeline

Open interactive timeline →
Jay Biotech Limited
Premium access

Shareholding and investment profile for Ushaben Gigabhai Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ushaben Gigabhai Rathod

Ushaben Gigabhai Rathod currently holds 1 directorship: Jay Biotech Limited (Director, since 10 May 2008, revenue ₹32.5 Lakh (FY 2025)).

Ushaben Gigabhai Rathod was first appointed on 10 May 2008 as Director at Jay Biotech Limited.

The current boards of Ushaben Gigabhai Rathod's companies include Gigabhai Mandanbhai Rathod (Jay Biotech Limited), Vimalkumar Gigabhai Rathod (Jay Biotech Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available